Lasa Supergenerics Ltd

LASA NSE Healthcare Pharmaceuticals
₹6.50
-0.31%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.2.
  • Promoters hold a majority stake (53.65%).

!Watch-points

  • Return on equity is on the lower side at -19.6%.
  • Return on capital employed is on the lower side at -18.2%.
  • The company reported a net loss in the latest period.
  • Sales growth has been slow over five years (about -34% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.33

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
1 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 33 Cr
Current Price₹ 6.50
High / Low₹ 14.08 / 5.67
Stock P/E
Book Value₹ 9.90
Dividend Yield0%
ROCE-18.20%
ROE-19.60%
Face Value₹ 10.00
Debt to Equity0.20
PEG Ratio
EV / EBITDA
Industry PE35.70
P/B Ratio0.6572295
EPS₹ -6.80
Debt₹ 10 Cr
PAT Margin-136.00%
Cash PAT₹ -28 Cr
ICR
Promoter Holding53.65%
FII Holding0.00%
DII Holding
Public Holding46.35%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years -34.00%
3 Years -42.00%
TTM -95.00%
Compounded Profit Growth
10 Years
5 Years
3 Years 10.00%
TTM -547.00%
Stock Price CAGR
10 Years
5 Years -38.00%
3 Years -38.00%
1 Year -44.00%
Return on Equity
10 Years 1.00%
5 Years -8.00%
3 Years -10.00%
Last Year -20.00%
Educational data only. Not a recommendation to buy, sell or hold any security.